Somatic molecular changes and histo-pathological features of colorectal cancer in Tunisia

被引:8
作者
Aissi, Sana [1 ,2 ]
Buisine, Marie Pierre [2 ,3 ,4 ]
Zerimech, Farid [3 ]
Kourda, Nadia [5 ]
Moussa, Amel [6 ]
Manai, Mohamed [1 ]
Porchet, Nicole [2 ,3 ,4 ]
机构
[1] Sci Univ Tunis, Biochem & Mol Biol Lab, El Manar Tunis 2092, Tunisia
[2] Ctr Rech Jean Pierre Aubert, INSERM U837, F-59000 Lille, France
[3] CHRU Lille, Biochem & Mol Biol Lab, F-59000 Lille, France
[4] Univ Lille Nord France, Med Univ H Warembourg, F-59045 Lille, France
[5] Charles Nicolle Hosp Tunis, Anatomopathol Dept, Tunis 1006, Tunisia
[6] Charles Nicolle Hosp Tunis, Dept Gastroenterol, Tunis 1006, Tunisia
关键词
DNA mismatch repair; KRAS; TP53; Mucin; 5AC; ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUTATION ANALYSIS; K-RAS; GENE; P53; DNA; CARCINOMAS; EXPRESSION;
D O I
10.3748/wjg.v19.i32.5286
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
AIM: To determine correlations between family history, clinical features and mutational status of genes involved in the progression of colorectal cancer (CRC). METHODS: Histo-pathological features and molecular changes [KRAS, BRAF and CTNNB1 genes mutations, microsatellite instability (MSI) phenotype, expression of mismatch repair (MMR) and mucin (MUC) 5AC proteins, mutation and expression analysis of TP53, MLH1 promoter hypermethylation analysis] were examined in a series of 51 unselected Tunisian CRC patients, 10 of them had a proven or probable hereditary disease, on the track of new tumoral markers for CRC susceptibility in Tunisian patients. RESULTS: As expected, MSI and MMR expression loss were associated to the presence of familial CRC (75% vs 9%, P < 0.001). However, no significant associations have been detected between personal or familial cancer history and KRAS (codons 12 and 13) or TP53 (exons 4-9) alterations. A significant inverse relationship has been observed between the presence of MSI and TP53 accumulation (10.0% vs 48.8%, P = 0.0335) in CRC tumors, suggesting different molecular pathways to CRC that in turn may reflect different environmental exposures. Interestingly, MUC5AC expression was significantly associated to the presence of MSI (46.7% vs 8.3%, P = 0.0039), MMR expression loss (46.7% vs 8.3%, P = 0.0039) and the presence of familial CRC (63% vs 23%, P = 0.039). CONCLUSION: These findings suggest that MUC5AC expression analysis may be useful in the screening of Tunisian patients with high risk of CRC. (c) 2013 Baishideng. All rights reserved.
引用
收藏
页码:5286 / 5294
页数:9
相关论文
共 37 条
[1]
Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease [J].
Aaltonen, LA ;
Salovaara, R ;
Kristo, P ;
Canzian, F ;
Hemminki, A ;
Peltomäki, P ;
Chadwick, RB ;
Kääriäinen, H ;
Eskelinen, M ;
Järvinen, H ;
Mecklin, JP ;
de la Chapelle, A ;
Percesepe, A ;
Ahtola, H ;
Härkönen, N ;
Julkunen, R ;
Kangas, E ;
Ojala, S ;
Tulikoura, J ;
ValKamo, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) :1481-1487
[2]
Lynch syndrome in Tunisia: first description of clinical features and germline mutations [J].
Aissi-Ben Moussa, Sana ;
Moussa, Amel ;
Kourda, Nadia ;
Mezlini, Amel ;
Abdelli, Nabil ;
Zerimech, Farid ;
Najjar, Taoufik ;
Ben Jilani, Sarah ;
Porchet, Nicole ;
Ben Ayed, Farhat ;
Manai, Mohamed ;
Buisine, Marie-Pierre .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2011, 26 (04) :455-467
[3]
Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination [J].
Aissi-Ben Moussa, Sana ;
Moussa, Amel ;
Lovecchio, Tonio ;
Kourda, Nadia ;
Najjar, Taoufik ;
Ben Jilani, Sarra ;
El Gaaied, Amel ;
Porchet, Nicole ;
Manai, Mohamed ;
Buisine, Marie-Pierre .
FAMILIAL CANCER, 2009, 8 (02) :119-126
[4]
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].
Amado, Rafael G. ;
Wolf, Michael ;
Peeters, Marc ;
Van Cutsem, Eric ;
Siena, Salvatore ;
Freeman, Daniel J. ;
Juan, Todd ;
Sikorski, Robert ;
Suggs, Sid ;
Radinsky, Robert ;
Patterson, Scott D. ;
Chang, David D. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634
[5]
Biemer-Hüttmann AE, 2000, CLIN CANCER RES, V6, P1909
[6]
Borresen-Dale AL, 1998, CLIN CANCER RES, V4, P203
[7]
Mucin gene expression in human embryonic and fetal intestine [J].
Buisine, MP ;
Devisme, L ;
Savidge, TC ;
Gespach, C ;
Gosselin, B ;
Porchet, N ;
Aubert, JP .
GUT, 1998, 43 (04) :519-524
[8]
Mutation analysis of p53, k-ras, and BRAF genes in colorectal cancer progression [J].
Calistri, D ;
Rengucci, C ;
Seymour, I ;
Lattuneddu, A ;
Polifemo, AM ;
Monti, F ;
Saragoni, L ;
Amadori, D .
JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 204 (02) :484-488
[9]
Mutations of the BRAF gene in human cancer [J].
Davies, H ;
Bignell, GR ;
Cox, C ;
Stephens, P ;
Edkins, S ;
Clegg, S ;
Teague, J ;
Woffendin, H ;
Garnett, MJ ;
Bottomley, W ;
Davis, N ;
Dicks, N ;
Ewing, R ;
Floyd, Y ;
Gray, K ;
Hall, S ;
Hawes, R ;
Hughes, J ;
Kosmidou, V ;
Menzies, A ;
Mould, C ;
Parker, A ;
Stevens, C ;
Watt, S ;
Hooper, S ;
Wilson, R ;
Jayatilake, H ;
Gusterson, BA ;
Cooper, C ;
Shipley, J ;
Hargrave, D ;
Pritchard-Jones, K ;
Maitland, N ;
Chenevix-Trench, G ;
Riggins, GJ ;
Bigner, DD ;
Palmieri, G ;
Cossu, A ;
Flanagan, A ;
Nicholson, A ;
Ho, JWC ;
Leung, SY ;
Yuen, ST ;
Weber, BL ;
Siegler, HF ;
Darrow, TL ;
Paterson, H ;
Marais, R ;
Marshall, CJ ;
Wooster, R .
NATURE, 2002, 417 (6892) :949-954
[10]
P53 mutation analysis of colorectal liver metastases: Relation to actual survival, angiogenic status, and p53 overexpression [J].
de Jong, KP ;
Gouw, ASH ;
Peeters, PMJG ;
Bulthuis, M ;
Menkema, L ;
Porte, RJ ;
Slooff, MJH ;
van Goor, H ;
van den Berg, A .
CLINICAL CANCER RESEARCH, 2005, 11 (11) :4067-4073